News

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
Moderna said on Wednesday it had withdrawn the pending application for its flu and COVID combination vaccine candidate for ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...